Chemists to aid the community for open antimicrobial drug discovery (CO-ADD)

The antibiotic pipeline is broken, with few new antibiotics and little current pharmaceutical company research. Antibacterial drugs have unique properties that are vastly different to drugs developed for other indications. CO-ADD believes that the laboratories of academic chemists contain unique compounds that have never been tested for their antimicrobial potential.

CO-ADD is a global open-access screening initiative to uncover untested chemical diversity. CO-ADD will provide free antimicrobial testing for any interested academic researcher. It builds upon antimicrobial expertise at The University of Queensland, and aims to unearth fresh chemical diversity for the treatment of microbial infections. CO-ADD will test researcher's compounds for their ability to kill pathogenic bacteria and fungi.

We are asking chemists and academics across the world if they have the next antibiotic?

CO-ADD's program coordinator Dr Mark Blaskovich invites chemists to join the Community for Open Antimicrobial Drug Discovery (CO-ADD) to uncover new antibiotics.

ACSPOD at the 249th ACS (American Chemical Society) conference in Denver - March 2015.